Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study.

Takero Hirata,Osamu Suzuki,Keisuke Otani, Akimitsu Miyake,Keisuke Tamari,Yuji Seo,Fumiaki Isohashi, Naoki Kai,Koji Hatano,Kazutoshi Fujita,Motohide Uemura,Ryoichi Imamura, Setsuo Tamenaga,Yutaro Yoshino,Yasutoshi Fumimoto,Yasuo Yoshioka,Norio Nonomura,Kazuhiko Ogawa

Acta oncologica (Stockholm, Sweden)（2023）

引用 0|浏览4

暂无评分

摘要

An SBRT dose of 35 Gy per 5 fractions is less likely to cause adverse events in patients with PCa than 375- and 40-Gy SBRT doses. Higher doses of SBRT should be applied with caution.

查看译文

关键词

Prostate cancer, SBRT, SABR, radiation therapy, toxicity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要